LuisAGuzmanMD

PubMed

• A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospecti...
  Rollini F, Franchi F, Cho JR, DeGroat C, Bhatti M, Muniz-Lozano A, Singh K, Ferrante E, Wilson RE, Dunn EC, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ> ;Eur. Heart J.. 2016-09-14
• Should endovascular approach be the first line of treatment for retroperitoneal bleeding with hemodynamic shock following percutaneous intervention? A case series.
  Seropian IM, Angiolillo DJ, Zenni MM, Bass TA, Guzman LA> ;Catheter Cardiovasc Interv. 2016-08-27
• 95 citations
  Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH Study
  Fabiana Rollini, Francesco Franchi, Jenny Hu, Megha Kureti, Niti Aggarwal, Ashwin Durairaj, Yongwhi Park, Michael Seawell, Pedro Cox-Alomar, Martin M. Zenni, Luis A. G...> ;Journal of the American College of Cardiology. 2016 May 3
• Meta-Analysis of Radial Versus Femoral Artery Approach for Coronary Procedures in Patients With Previous Coronary Artery Bypass Grafting.
  Rigattieri S, Sciahbasi A, Brilakis ES, Burzotta F, Rathore S, Pugliese FR, Fedele S, Ziakas AG, Zhou YJ, Guzman LA, Anderson RA> ;Am. J. Cardiol.. 2016-04-15
• Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogr...
  Franchi F, Rollini F, Cho JR, King R, Phoenix F, Bhatti M, DeGroat C, Tello-Montoliu A, Zenni MM, Guzman LA, Bass TA, Ajjan RA, Angiolillo DJ> ;Thromb. Haemost.. 2016-03-01
• Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.
  Angiolillo DJ, Jakubowski JA, Ferreiro JL, Tello-Montoliu A, Rollini F, Franchi F, Ueno M, Darlington A, Desai B, Moser BA, Sugidachi A, Guzman LA, Bass TA> ;J. Am. Coll. Cardiol.. 2014-09-09
• Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease.
  Darlington A, Tello-Montoliu A, Rollini F, Ueno M, Ferreiro JL, Patel R, Desai B, Guzman LA, Bass TA, Angiolillo DJ> ;Thromb. Haemost.. 2014-02-01
• A polypill strategy to improve adherence: results from the FOCUS project.
  Castellano JM, Sanz G, Peñalvo JL, Bansilal S, Fernández-Ortiz A, Alvarez L, Guzmán L, Linares JC, García F, D'Aniello F, Arnáiz JA, Varea S, Martínez F, Lorenzatti A,...> ;J. Am. Coll. Cardiol.. 2014-01-01
• Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigation.
  Tello-Montoliu A, Thano E, Rollini F, Patel R, Wilson RE, Muñiz-Lozano A, Franchi F, Darlington A, Desai B, Guzman LA, Bass TA, Angiolillo DJ> ;Thromb. Haemost.. 2013-10-01
• Candidates for transcatheter aortic valve replacement: fitting the PARTNERS criteria.
  Babcock MJ, Lavine S, Strom JA, Bass TA, Guzman LA> ;Catheter Cardiovasc Interv. 2013-10-01
• Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus.
  Suryadevara S, Ueno M, Tello-Montoliu A, Ferreiro JL, Desai B, Rollini F, Box LC, Zenni M, Guzman LA, Bass TA, Angiolillo DJ> ;Thromb. Haemost.. 2012-11-01
• Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized study.
  Tello-Montoliu A, Tomasello SD, Ferreiro JL, Ueno M, Seecheran N, Desai B, Kodali M, Charlton RK, Box LC, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ> ;J. Am. Coll. Cardiol.. 2012-05-08
• Differences in Treatment Patterns and Outcomes Between Hispanics and Non-Hispanic Whites Treated for ST-Segment Elevation Myocardial Infarction Results From the NCDR A...
  Guzman, L. A., Li, S., Wang, T. Y., Daviglus, M. L., Exaire, J., Rodriguez, C. J., Torres, V. I., Funk, M., Saucedo, J., Granger, C., Piña, I. L., Cohen, M. G.> ;J Am Coll Cardiol. 2012 Feb 7
• The fixed-dose combination drug for secondary cardiovascular prevention project: improving equitable access and adherence to secondary cardiovascular prevention with a...
  Sanz G, Fuster V, Guzmán L, Guglietta A, Arnáiz JA, Martínez F, Sarria A, Roncaglioni MC, Taubert K> ;Am. Heart J.. 2011-11-01
• Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.
  Angiolillo, D. J., Capranzano, P., Ferreiro, J. L., Ueno, M., Capodanno, D., Dharmashankar, K., Darlington, A., Sumner, S., Desai, B., Charlton, R. K., Box, L. C., Zen...> ;Thromb Haemost. 2011 Aug
• Glycoprotein IIb/IIIa inhibitors to facilitate percutaneous intervention in ST-elevation myocardial infarction: the sooner not necessarily the better.
  Guzman, L. A.> ;Circ J. 2010 Aug
• Pre-eclampsia associated with carotid dissection and stroke in a young woman.
  Dasgupta, N.R., Guzman, L.A., Chapman, D.B.> ;J Stroke Cerebrovasc Dis. 2010 Mar
• Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards.
  Kandzari, D. E., Colombo, A., Park, S. J., Tommaso, C. L., Ellis, S. G., Guzman, L. A., Teirstein, P. S., Tamburino, C., Ormiston, J., Stone, G. W., Dangas, G. D., Pop...> ;J Am Coll Cardiol. 2009 Oct 17
• Impact of P2Y(12) inhibitory effects induced by clopidogrel on platelet procoagulant activity in type 2 diabetes mellitus patients.
  Angiolillo, D.J., Capranzano, P., Desai, B., Shoemaker, S.B., Charlton, R., Zenni, M.M., Guzman, L.A., Bass, T.A.> ;Thromb Res. 2009 Jul 01
• Long-term clinical outcomes after drug-eluting stent implantation in unprotected left main coronary artery disease.
  Tamburino, C., Angiolillo, D.J., Capranzano, P., Di Salvo, M., Ussia, G., La Manna, A., Guzman, L.A., Galassi, A.R., Bass, T.A.> ;Catheter Cardiovasc Interv. 2009 Feb 15
• Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.
  Angiolillo, D. J., Suryadevara, S., Capranzano, P., Zenni, M. Z., Guzman, L. A., Bass, T. A.> ;Catheter Cardiovasc Interv. 2009 Jan 01
• Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents.
  Suzuki, N., Angiolillo, D. J., Monteiro, C., Shuja, S., Futamatsu, H., Kawaguchi, R., Box, L. C., Guzman, L., Zenni, M. M., Gilmore, P. S., Bass, T. A., Costa, M. A.> ;Int J Cardiol. 2008 Nov 28
• Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents.
  Tamburino, C., Angiolillo, D.J., Capranzano, P., Dimopoulos, K., La Manna, A., Barbagallo, R., Tagliareni, F., Mangiafico, S., Guzman, L.A., Galassi, A.R., Bass, T.A.> ;Catheter Cardiovasc Interv. 2008 Oct 01
• 153 citations
  A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet...
  Dominick J. Angiolillo, Piera Capranzano, Shinya Goto, Mohammed Aslam, Bhaloo Desai, Ronald K. Charlton, Yoshie Suzuki, Lyndon C. Box, Steven B. Shoemaker, Martin M. Z...> ;European Heart Journal. 2008 Sep 1
• Clinical overview of promising nonthienopyridine antiplatelet agents.
  Angiolillo, D.J., Guzman, L.A.> ;Am Heart J. 2008 Aug
• Join now to see all